Literature DB >> 12923350

Tension-free vaginal tape procedure: an effective minimally invasive operation for the treatment of recurrent stress urinary incontinence?

Nina Kuuva1, Carl Gustaf Nilsson.   

Abstract

The aim of this study was to evaluate the results of tension-free vaginal tape (TVT) surgery in women with recurrent stress urinary incontinence (SUI). Fifty-one women with recurrent SUI were treated with TVT and followed prospectively for a minimum of 2 years according to a protocol. Twenty percent of the women had already undergone two previous continence procedures, whereas 80% had undergone only one. The mean follow-up period was 25.3 months. The objective cure rate was 89.6%, and the subjective cure rate 80.4%. No serious complications occurred. The majority of the patients were discharged in the afternoon of the operation day. No significant difference was observed between pre- and postoperative residual urine, maximal urethral closure pressure, and total and maximum voided urine volume values. However, the changes in urinary frequency, minimum voided volume, pad test results, and visual analog scale scores were highly significant. TVT appears to be a safe and suitable treatment for recurrent SUI. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12923350     DOI: 10.1159/000072942

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  11 in total

Review 1.  Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis.

Authors:  Ashish Pradhan; Preeti Jain; Pallavi M Latthe
Journal:  Int Urogynecol J       Date:  2012-05-11       Impact factor: 2.894

2.  Creating a gold standard surgical procedure: the development and implementation of TVT.

Authors:  Carl Gustaf Nilsson
Journal:  Int Urogynecol J       Date:  2015-04       Impact factor: 2.894

3.  Vaginal erosion, sinus formation, and ischiorectal abscess following transobturator tape: ObTape implantation.

Authors:  Ebenezer O Babalola; Abimbola O Famuyide; Lois J McGuire; John B Gebhart; Christopher J Klingele
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-09-27

4.  The evolution of surgical treatment for female stress urinary incontinence: era of mid-urethral slings.

Authors:  Young-Suk Lee; Ha Na Lee; Kyu-Sung Lee
Journal:  Korean J Urol       Date:  2010-04-20

5.  Effectiveness of the TVT procedure as a repeat mid-urethra operation for treatment of stress incontinence.

Authors:  K Palva; C G Nilsson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-10

6.  Patient-reported outcomes for tension-free vaginal tape-obturator in women treated with a previous anti-incontinence procedure.

Authors:  Grace Y Biggs; Katie N Ballert; Nirit Rosenblum; Victor Nitti
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-12-24

7.  A randomized trial comparing TVT with TVT-O: 12-month results.

Authors:  Kirsi Rinne; Eija Laurikainen; Arre Kivelä; Pauliina Aukee; Teuvo Takala; Antti Valpas; Carl Gustaf Nilsson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-29

8.  A multi-centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension-free, suburethral sling treatment of urodynamic stress incontinence: the TORP study.

Authors:  Christopher Barry; Yik Nyok Lim; Reinhold Muller; Sarah Hitchins; Audrey Corstiaans; Andrew Foote; Hugh Greenland; Malcolm Frazer; Ajay Rane
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-07-19

9.  The tension-free vaginal tape in women with a non-hypermobile urethra and low maximum urethral closure pressure.

Authors:  Jeffrey L Clemons; Christine A LaSala
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-11

Review 10.  Is there still a place for the pubovaginal sling at the bladder neck in the era of the midurethral sling?

Authors:  Woodie J Wilson; J Christian Winters
Journal:  Curr Urol Rep       Date:  2005-09       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.